Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
Recent Posts
- To Heal Skin, Scientists Invent Living Bioelectronics.
- Register for Children’s Specialized Hospital Distinguished Lecture on 8/14
- Researchers Shed Light on Cause of ‘Happy Hypoxia’ in COVID-19 Patients.
- Upending Conventional Wisdom, Cannabis Use Doesn’t Hinder PTSD Therapy.
- Many Firearm Owners Can’t Recognize When a Cable Lock Is Properly Installed.
Categories
- Community (1,944)
- Covid (971)
- CTO Events (1)
- News (2,488)
- Pilots (20)